86 Opsonisation and Nitrobluetetrazolium (NBT) reduction by granulocytes (gr) in exchangetransfusions (ET) of newborns. Gr. of 4 of them, collected before ET afid incubate3 with donors sera increased their 01 (1.7~0~2 to 4.620.3, p<0.005), which claims for opsonlnes ~mportance. 13 donors with normal NBT test (9522%) induced: no change in 6 infants with normal gr. and a normalisation of the previously low value (45213%) in 4 babies. 5 donors with reduced NBT test value (66+6%) induced no effect on normal receivers whereas Pdonors with low value (26+6%) depressed the gr. activity of the receivers (81+4-to 58+9%). ET can influence positively or negatively granulzc~tic functions. Immunologic studies of donors' and receivers' granulocytes should help for indication of ET in septicemia and sclerema of newborns. A report will be given on 160 chilaren from the five Nordic countries who had their antileukemic therapy discontinued prior to November, 1976. Twenty-seven of the 160 cases (17 6 ) had suffered a relapse before May 1977. Sixty-nine had their therapy stopped in the first ten months of 1976. 'I'hirty-five first line patients treated for more than 3 years, without cessation of therapy, are also included in the report. Different types of therapy have been used. Central nervous system or testicular relapse occurred in 21 of the total 44 cases who relapsed after three years or more of continuous remission, and whether they were on therapy or not. A further follow up on the 160 children and in another 50 cases off therapy will be presented. Cessation of therapy after three years of primary remission is now common in the Nordic countries and have even successfully been performed in a few cases after three or more years of secondary remission.
C.ALTAY' G.DINC~:*, M.AKSOY~*, A.GURGEY'*. and T H.; HUISMAN 88 l-~e~irtrnint of Pediatrics, Hacettepe University, Ankara, Turkey 2-Department of Internal Medicine. Istanbul University, Istanbul, Turkey 3-Department of Cell and Molecular Biology, Medical College of Georgia. Augusta. Georgia Biosynthetic and structural studies in two unrelated cases of hornozygous -thalassernia. Two unrelated Turkish children were found to be homozygous fat-&a -thalassernia. Starch gel electrophoresis at pH 9.0 revealed only an HbF band in OaLh case and an AFA pattern from all the parents. HbA was not detectab20 in the patients and the level was2within normal limits in the parents by column chromatography. Structural analysis of HbF indicated the presence of an A& :Gr ratio at adult level, and, interestingly, Threonine was not present at the 75th position of the chain. Invitro hemoglobin synthesis gave a nono(7d ratio of 0.24 and 0.20 from the patients. The ratios in the parents were 0.48 and 0.44 in one family and 0.38 and 0.27 in the other. Vitamin B 12 in blood is transported by specific carrier proteins, the transcobalamins (TC 1,II and 111). TC I1 is of particular interest since it carries and delivers vitamin B12 to the cells. Polyacrylamid gel electrophoresis was used to separate TC I and I11 from TC 11. Autoradiographic evaluation showed that the TC I1 fraction is composed of 2, 3 or 4 discrete bands in individual serum samples. This observation and family studies have recently led to the conclusion that these isoprotein patterns present polymorphic variants of TC 11. Absolute radioactivity of the gel and relative intensities of the radioactive bands were used to quantitate the TC I1 fractions.
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Unsaturated TC I1 levels were also determined using a new immunochemical method, based on the preci itation of TC I1 by insolubilised anti-TC I1 antiserum ?radio immunosorbent technique = RIST). The results of TC I1 determinations with these two basically different assays correlate satisfactorily. ~ranscobalamin I1 (TC 11) is a serum protein responsible for transporting vitamin B12 to the cells. A possible function of TC I1 in the immune response was suggested by lack of antibody synthesis and agammaglobulinemia in a child with congenital TC I1 deficiency. Therefore TC I1 levels in patients with autoimmune diseases (= AID) as lupus erythematodes, dermatomyositis and autoimmune hemolytic anemia and with acquired immunodeficiency states due to chemotherapy (prednisone, azathioprine, chlorambucil) were determined. TC I1 was usually elevated 2-5 fold in untreated AID, normal in AID under therapy in remission, increased 1.5-3 fold in treated but active AID and normal or elevated 1.5 fold in individuals after renal transplantation. Thus immunosuppressive treatment does not depress the synthesis of TC 11, on the contrary, TC I1 concentration can be significantly elevated during immunosuppressive therapy. It appears that TC I1 levelsin the group of AID patients correlate better with the clinical course than complement, antinuclear antibody or antinative DNA antibody titers. This suggests that TC I1 determination could be an additional valuable test to follow up activity of AID.
